Jaeghere, E. A. D., Tuyaerts, S., Nufel, A. M. T. V., Belmans, A., Bogaerts, K., Baiden-Amissah, R., . . . Denys, H. G. Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study. Springer.
Chicago Style (17th ed.) CitationJaeghere, Emiel A. De, et al. Correction: Pembrolizumab, Radiotherapy, and an Immunomodulatory Five-drug Cocktail in Pretreated Patients with Persistent, Recurrent, or Metastatic Cervical or Endometrial Carcinoma: Results of the Phase II PRIMMO Study. Springer.
MLA (9th ed.) CitationJaeghere, Emiel A. De, et al. Correction: Pembrolizumab, Radiotherapy, and an Immunomodulatory Five-drug Cocktail in Pretreated Patients with Persistent, Recurrent, or Metastatic Cervical or Endometrial Carcinoma: Results of the Phase II PRIMMO Study. Springer.